FIELD: medicine.
SUBSTANCE: drugs contain H-SGK kinase having lysine substituted by arginine in position 127.
EFFECT: enhanced effectiveness in treating states for which sodium channel and/or Na+, K+, 2Cl- cocarrier activity is to be reduced.
2 cl, 6 dwg
Authors
Dates
2006-12-10—Published
2000-04-19—Filed